South Korea Analysis

Pages

Industry Trend Analysis - Biosimilars To Drive Domestic Industry Growth - FEB 2015

Biosimilars will be a key driver of growth for the South Korean pharmaceutical industry. Local manufacturers will boosted by a supportive domestic environment and the upcoming patent expirations for a number of biologic medicines. We highlight that South Korean companies with a focus on biosimilars, including Celltrion, will be well placed to leverage the commercial opportunities.

READ FULL ARTICLE

Pages